Neutrogena Beach Defense Sunscreen Spray Recalled for cGMP Deviations
Johnson & Johnson Consumer is recalling Neutrogena Beach Defense water + sun protection sunscreen spray in two sizes (6.5 oz and 8.5 oz) nationwide due to current good manufacturing practice (cGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall initiated by the firm for cGMP deviations. The source text does not report any illnesses, injuries, or confirmed product failures—only potential manufacturing control issues. Per the severity rubric, a Class II recall without reported harm is classified as Moderate.
Plain-English summary
Johnson & Johnson Consumer, Inc. is voluntarily recalling Neutrogena Beach Defense water + sun protection sunscreen spray BROAD SPECTRUM SPF 30 (Avobenzone 3%, Homosalate 8%, Octisalate 5%, Octocrylene 8%) in two sizes: 6.5 oz (184 g) with UPC 0 86800 87273 3 and 8.5 oz (240 g) with UPC 0 86800 10032 4. A total of 1,265,724 cans of the 6.5 oz size and 1,052,544 cans of the 8.5 oz size have been distributed nationwide in the United States.
The recall was initiated because the firm identified current good manufacturing practice (cGMP) deviations during manufacturing. The product was distributed nationwide, and all lots remaining in distribution are within expiry dates.
Consumers who have purchased this product should stop using it. For more information, contact the FDA or Johnson & Johnson Consumer, Inc. at Skillman, NJ 08858.
The recalled product
- Product
- Neutrogena Beach Defense water + sun protection sunscreen spray BROAD SPECTRUM SPF 30, Avobenzone (3%), Homosalate (8%), Octisalate (5%), Octocrylene (8%), a) NET WT. 6.5 OZ (184 g) (UPC 0 86800 87273 3) and b) NET WT. 8.5 oz (240 g) (UPC 0 86800 10032 4) aerosol can, Distributed
- Manufacturer
- Johnson & Johnson Consumer, Inc.
- Category
- Drug — Sunscreen
- Hazard
- cGMP-deviation
- manufacturing-control
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27